UnitedHealth Group (UNH) Q3 2026 Financial Results Summary
QuoteReporter
UnitedHealth Group (UNH) Q3 2026: Revenue Decline, Earnings Growth — Cautiously Optimistic
UnitedHealth Group (NYSE: UNH) reported its third quarter 2026 results, revealing a mixed performance compared to the previous year. Revenues for the quarter were $112.7 billion, a decrease of $0.5 billion or -0.4% from $113.2 billion in Q3 2025. However, earnings from operations surged to $6.6 billion, up $2.3 billion or +53.5% from $4.3 billion in the same quarter last year. This indicates a strong operational performance despite the revenue decline.
Analyst View
This quarter presents a cautiously optimistic outlook for shareholders. While the revenue decline may raise concerns, the significant increase in earnings from operations demonstrates effective cost management and operational efficiencies. The company’s ability to improve its earnings margin, alongside a robust cash flow from operations of $5.1 billion, suggests that UnitedHealth is navigating the current healthcare landscape effectively.
Key Metrics
- Revenues: $112.7 billion (Q3 2025: $113.2 billion) — a decrease of $0.5 billion or -0.4% YoY.
- Earnings from Operations: $6.6 billion (Q3 2025: $4.3 billion) — an increase of $2.3 billion or +53.5% YoY.
- Net Margin: 3.6% (Q3 2025: 2.1%).
- Cash Flows from Operations: $5.1 billion, or 1.2x net income.
- Medical Care Ratio: 88.4% (Q3 2025: 89.9%).
- Operating Cost Ratio: 12.8% (Q3 2025: 13.5%).
- Debt-to-Capital Ratio: 41.7% as of September 30, 2026.
Dividend and Share Buyback
UnitedHealth Group has continued its commitment to returning value to shareholders, having repurchased $5.0 billion of its common stock and paid $6.2 billion in dividends year-to-date. This reflects the company's strong cash position and commitment to shareholder returns.
Guidance Update
The company has updated its full-year 2026 earnings outlook to at least $19.50 per share, with adjusted earnings expected to be at least $20.50 per share. This upward revision in guidance is a positive signal for investors, indicating confidence in the company’s operational performance moving forward.
Forward Catalysts
Investors should watch for the upcoming developments in UnitedHealth's strategic initiatives aimed at enhancing healthcare affordability and access. The company is actively addressing healthcare challenges through various commitments, including a $1 billion investment in the United Health Foundation to improve rural healthcare and maternal health. Additionally, the expansion of coverage for doula care and behavioral health coaching will be critical to monitor as these initiatives could significantly impact membership growth and retention.
In conclusion, while the revenue decline may be a concern, the substantial growth in earnings and the proactive measures taken by UnitedHealth Group position the company favorably for the future. Investors should remain attentive to the execution of strategic initiatives and the impact of ongoing healthcare reforms as they evaluate the company's performance in the upcoming quarters.
Note: The following tables present amounts in millions.
| Three Months Ended September 30 | 2026 | 2025 | 2026 | 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Premiums | $87,078 | $88,979 | $261,595 | $263,418 |
| Products | 14,293 | 13,296 | 41,378 | 39,896 |
| Services | 10,246 | 9,754 | 30,043 | 27,765 |
| Investment and other income | 1,077 | 1,132 | 3,431 | 3,273 |
| Total revenues | 112,694 | 113,161 | 336,447 | 334,352 |
| Operating costs | ||||
| Medical costs | 76,982 | 79,958 | 225,829 | 231,954 |
| Operating costs | 14,369 | 15,223 | 44,027 | 42,595 |
| Cost of products sold | 13,707 | 12,566 | 39,905 | 37,975 |
| Depreciation and amortization | 1,073 | 1,099 | 3,142 | 3,244 |
| Total operating costs | 106,131 | 108,846 | 312,903 | 315,768 |
| Earnings from operations | 6,563 | 4,315 | 23,544 | 18,584 |
| Interest expense | (963) | (1,003) | (2,880) | (3,028) |
| Loss on sale of subsidiary | (76) | (83) | (209) | (139) |
| Earnings before income taxes | 5,524 | 3,229 | 20,455 | 15,417 |
| Provision for income taxes | (1,224) | (686) | (4,004) | (2,828) |
| Net earnings | 4,300 | 2,543 | 16,451 | 12,589 |
| Earnings attributable to noncontrolling interests | (190) | (195) | (577) | (543) |
| Net earnings attributable to UnitedHealth Group common shareholders | $4,110 | $2,348 | $15,874 | $12,046 |
| Diluted earnings per share | $4.56 | $2.59 | $17.50 | $13.21 |
| Adjusted earnings per share | $4.69 | $2.92 | $18.30 | $14.22 |
| Diluted weighted-average common shares outstanding | 902 | 908 | 906 | 912 |
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Cash and short-term investments | $28,549 | $28,121 |
| Accounts receivable, net | 20,543 | 23,018 |
| Other current assets | 36,503 | 39,443 |
| Total current assets | 85,595 | 90,582 |
| Long-term investments | 58,064 | 54,251 |
| Other long-term assets | 169,123 | 164,748 |
| Total assets | $312,782 | $309,581 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Medical costs payable | 39,352 | 39,337 |
| Short-term borrowings and current maturities of long-term debt | 5,617 | 6,069 |
| Other current liabilities | 70,866 | 69,491 |
| Total current liabilities | 115,835 | 114,897 |
| Long-term debt, less current maturities | 68,714 | 72,320 |
| Other long-term liabilities | 22,688 | 20,666 |
| Redeemable noncontrolling interests | 1,416 | 1,608 |
| Equity | 104,129 | 100,090 |
| Total liabilities, redeemable noncontrolling interests and equity | $312,782 | $309,581 |
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.
